Suheung Co., Ltd. (008490.KS)
KRW 12880.0
(-1.68%)
KRW 12880.0
(-1.68%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 259.84 Billion KRW | 9.72% |
| 2022 | 236.81 Billion KRW | 30.12% |
| 2021 | 181.99 Billion KRW | 9.39% |
| 2020 | 166.37 Billion KRW | 17.99% |
| 2019 | 141 Billion KRW | 21.35% |
| 2018 | 116.19 Billion KRW | 4.11% |
| 2017 | 111.6 Billion KRW | -2.55% |
| 2016 | 114.52 Billion KRW | 10.32% |
| 2015 | 103.81 Billion KRW | 6.86% |
| 2014 | 97.15 Billion KRW | 4.4% |
| 2013 | 93.05 Billion KRW | 50.18% |
| 2012 | 61.96 Billion KRW | 14.43% |
| 2011 | 54.14 Billion KRW | 14.08% |
| 2010 | 47.46 Billion KRW | 27.03% |
| 2009 | 37.36 Billion KRW | 16.15% |
| 2008 | 32.16 Billion KRW | 25.89% |
| 2007 | 25.55 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 243.35 Billion KRW | -6.35% |
| 2024 Q2 | 248.44 Billion KRW | 2.09% |
| 2023 FY | 259.84 Billion KRW | 9.72% |
| 2023 Q4 | 259.84 Billion KRW | 2.66% |
| 2023 Q1 | 230.75 Billion KRW | -2.56% |
| 2023 Q3 | 253.09 Billion KRW | 4.48% |
| 2023 Q2 | 242.25 Billion KRW | 4.98% |
| 2022 Q1 | 184.65 Billion KRW | 1.46% |
| 2022 FY | 236.81 Billion KRW | 30.12% |
| 2022 Q4 | 236.81 Billion KRW | 6.44% |
| 2022 Q3 | 222.47 Billion KRW | 10.24% |
| 2022 Q2 | 201.81 Billion KRW | 9.29% |
| 2021 FY | 181.99 Billion KRW | 9.39% |
| 2021 Q1 | 157.18 Billion KRW | -5.53% |
| 2021 Q3 | 161.67 Billion KRW | 2.73% |
| 2021 Q4 | 181.99 Billion KRW | 12.57% |
| 2021 Q2 | 157.37 Billion KRW | 0.12% |
| 2020 Q3 | 149.01 Billion KRW | -1.77% |
| 2020 Q2 | 151.69 Billion KRW | 9.48% |
| 2020 Q1 | 138.56 Billion KRW | -1.73% |
| 2020 FY | 166.37 Billion KRW | 17.99% |
| 2020 Q4 | 166.37 Billion KRW | 11.65% |
| 2019 Q4 | 141 Billion KRW | 17.58% |
| 2019 FY | 141 Billion KRW | 21.35% |
| 2019 Q3 | 119.92 Billion KRW | 9.92% |
| 2019 Q2 | 109.1 Billion KRW | 2.15% |
| 2019 Q1 | 106.8 Billion KRW | -8.09% |
| 2018 FY | 116.19 Billion KRW | 4.11% |
| 2018 Q1 | 105.68 Billion KRW | -5.31% |
| 2018 Q2 | 102.9 Billion KRW | -2.63% |
| 2018 Q3 | 101.95 Billion KRW | -0.93% |
| 2018 Q4 | 116.19 Billion KRW | 13.97% |
| 2017 Q1 | 108.66 Billion KRW | -5.11% |
| 2017 FY | 111.6 Billion KRW | -2.55% |
| 2017 Q4 | 111.6 Billion KRW | 4.86% |
| 2017 Q3 | 106.43 Billion KRW | -1.03% |
| 2017 Q2 | 107.54 Billion KRW | -1.03% |
| 2016 FY | 114.52 Billion KRW | 10.32% |
| 2016 Q4 | 114.52 Billion KRW | 13.18% |
| 2016 Q2 | 105.33 Billion KRW | 3.43% |
| 2016 Q3 | 101.19 Billion KRW | -3.94% |
| 2016 Q1 | 101.84 Billion KRW | -1.9% |
| 2015 Q3 | 96.32 Billion KRW | -0.48% |
| 2015 Q4 | 103.81 Billion KRW | 7.78% |
| 2015 FY | 103.81 Billion KRW | 6.86% |
| 2015 Q2 | 96.79 Billion KRW | 0.43% |
| 2015 Q1 | 96.37 Billion KRW | -0.8% |
| 2014 Q2 | 91.03 Billion KRW | 0.8% |
| 2014 Q1 | 90.31 Billion KRW | -2.95% |
| 2014 Q3 | 92.55 Billion KRW | 1.67% |
| 2014 FY | 97.15 Billion KRW | 4.4% |
| 2014 Q4 | 97.15 Billion KRW | 4.97% |
| 2013 FY | 93.05 Billion KRW | 50.18% |
| 2013 Q4 | 93.05 Billion KRW | 13.4% |
| 2013 Q3 | 82.05 Billion KRW | 14.96% |
| 2013 Q2 | 71.37 Billion KRW | 12.42% |
| 2013 Q1 | 63.49 Billion KRW | 2.47% |
| 2012 Q1 | 34.34 Billion KRW | 0.0% |
| 2012 Q4 | 61.96 Billion KRW | 0.0% |
| 2012 FY | 61.96 Billion KRW | 14.43% |
| 2011 FY | 54.14 Billion KRW | 14.08% |
| 2011 Q3 | 33.53 Billion KRW | 16.44% |
| 2011 Q2 | 28.8 Billion KRW | 2.66% |
| 2011 Q1 | 28.05 Billion KRW | 0.0% |
| 2010 Q1 | 24.32 Billion KRW | 0.0% |
| 2010 Q3 | 24.88 Billion KRW | 5.93% |
| 2010 FY | 47.46 Billion KRW | 27.03% |
| 2010 Q2 | 23.49 Billion KRW | -3.41% |
| 2009 FY | 37.36 Billion KRW | 16.15% |
| 2009 Q3 | 23.19 Billion KRW | -0.48% |
| 2009 Q2 | 23.3 Billion KRW | 5.49% |
| 2009 Q1 | 22.09 Billion KRW | 0.0% |
| 2008 Q1 | 19.39 Billion KRW | 0.0% |
| 2008 FY | 32.16 Billion KRW | 25.89% |
| 2008 Q2 | 20.79 Billion KRW | 7.19% |
| 2008 Q3 | 21.96 Billion KRW | 5.61% |
| 2007 Q3 | 16.4 Billion KRW | -0.67% |
| 2007 Q1 | 16.57 Billion KRW | 0.0% |
| 2007 FY | 25.55 Billion KRW | 0.0% |
| 2007 Q2 | 16.51 Billion KRW | -0.34% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -488.514% |
| Dong-A Socio Holdings Co., Ltd. | 117.85 Billion KRW | -120.481% |
| Ildong Holdings Co., Ltd. | 91.16 Billion KRW | -185.019% |
| HANDOK Inc. | 94.46 Billion KRW | -175.068% |
| Kukje Pharma Co., Ltd. | 21.24 Billion KRW | -1123.181% |
| Yuhan Corporation | 284.75 Billion KRW | 8.75% |
| Dong-A ST Co., Ltd. | 116.31 Billion KRW | -123.397% |
| SAMSUNG PHARM. Co., LTD. | 16.25 Billion KRW | -1498.171% |
| Hanmi Pharm. Co., Ltd. | 288.81 Billion KRW | 10.031% |
| Hanall Biopharma Co.,Ltd | 32.38 Billion KRW | -702.373% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -320.969% |
| Dong Sung Bio Pharm.Co.,Ltd. | 19.47 Billion KRW | -1234.091% |
| MYUNGMOON Pharm co.,Ltd | 30.28 Billion KRW | -758.122% |
| Hana Pharm Co., Ltd. | 48.34 Billion KRW | -437.448% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -488.514% |
| Ilsung Pharmaceuticals Co., Ltd. | 31.24 Billion KRW | -731.739% |
| REYON Pharmaceutical Co., Ltd. | 35.17 Billion KRW | -638.681% |
| Aprogen pharmaceuticals,Inc. | 48.12 Billion KRW | -439.895% |
| JW Holdings Corporation | 147.58 Billion KRW | -76.057% |
| Ildong Pharmaceutical Co., Ltd. | 84.62 Billion KRW | -207.056% |
| Chong Kun Dang Pharmaceutical Corp. | 261.43 Billion KRW | 0.608% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -144.923% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -381.873% |
| Hyundai Pharmaceutical Co., Ltd. | 26.99 Billion KRW | -862.448% |
| Samil Pharmaceutical Co.,Ltd | 32.51 Billion KRW | -699.232% |
| Jeil Pharmaceutical Co.,Ltd | 109.76 Billion KRW | -136.719% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -488.514% |
| Kwang Dong Pharmaceutical Co., Ltd. | 188.64 Billion KRW | -37.743% |
| Daewoong pharmaceutical Co.,Ltd | 241.54 Billion KRW | -7.575% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -144.923% |
| Yuhan Corporation | 284.75 Billion KRW | 8.75% |
| Jeil Pharma Holdings Inc | 125.28 Billion KRW | -107.409% |
| Yungjin Pharm. Co., Ltd. | 61.98 Billion KRW | -319.19% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -144.923% |
| Samjin Pharmaceuticals Co., Ltd. | 79.6 Billion KRW | -226.423% |
| Korea United Pharm Inc. | 49.14 Billion KRW | -428.756% |
| CKD Bio Corp. | 69.08 Billion KRW | -276.134% |
| Daewon Pharmaceutical Co., Ltd. | 105.07 Billion KRW | -147.285% |
| Dongwha Pharm.Co.,Ltd | 70.69 Billion KRW | -267.542% |
| Whan In Pharm Co.,Ltd. | 54.05 Billion KRW | -380.672% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -381.873% |
| Chong Kun Dang Holdings Corp. | 194.76 Billion KRW | -33.413% |
| Boryung Corporation | 189.8 Billion KRW | -36.899% |
| Bukwang Pharmaceutical Co., Ltd. | 56.83 Billion KRW | -357.211% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -320.969% |
| JW Lifescience Corporation | 23.39 Billion KRW | -1010.5% |